Collection

PPRS: quarterly net sales and payment information

Provides information on how the Pharmaceutical Price Regulation Scheme (PPRS) is controlling spend on branded medicines in the NHS.

This page holds the NHS’s quarterly aggregate net sales and payment information on pharmaceuticals from 2013 to date.

The Pharmaceutical Price Regulation Scheme 2014 (PPRS) limits the growth in spend on branded medicines used by the NHS.

Under the scheme:

  • the amount the NHS spends on the branded medicines controlled by the scheme will remain flat for 2 years, followed by increases of less than 2% in the following 3 years
  • the industry will make payments to the Department of Health and Social Care if NHS spending on branded medicines exceeds the allowed growth rate
  • payments are based on the difference between the allowed percentage growth and the actual percentage growth in how much the NHS spends on branded medicines
  • PPRS payments are due one month after the end of each calendar quarter and are calculated based on suppliers’ returns on net sales for that quarter.

2018

2013 to 2017

Published 20 March 2018
Last updated 28 June 2018 + show all updates
  1. Added 'PPRS aggregate net sales and payment information: May 2018' to collection.
  2. First published.